Abstract P1-10-09: The MHCII immune activation assay is prognostic for disease free survival in basal-like TNBC breast cancer patients in the GEICAM/9906 clinical trial
Year: 2020
Type: conference-abstract
Source: Cancer Research
Authors: Miguel Martín, Katherine L Updike, Alvaro Rodríguez-Lescure, Lourdes Calvo, Jesús Herranz, Nuria Martín, Philip S Bernard, Katherine E Varley
Institutions: Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Cáncer, GEICAM – Spanish Breast Cancer Group, Instituto de Investigación Sanitaria Gregorio Marañón, University of Utah, Huntsman Cancer Institute, Hospital General Universitario de Elche, Complexo Hospitalario Universitario A Coruña
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3013017977